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Tumor necrosis factor aABSTRACT
Objective: To observe the protective effect of fasudil hydrochloride against acute renal
injury in septicopyemia rats.
Methods: A total of 60 Wister rats were included in the study and divided into control
group (n = 10), model group (n = 25) and treatment group (n = 25). Model group and
treatment group received intraperitoneal injection of endotoxin (ET) to establish acute
renal injury models while the control group only received daily intraperitoneal injection
of normal saline 1 mL. Five rats were taken out of model group and treatment group
respectively at 1 h (T1), 6 h (T2), 12 h (T3), 24 h (T4) and 48 h (T5), for intraperitoneal
injection of ET 30 mg/kg. Treatment group received intraperitoneal injection of fasudil
hydrochloride 30 mg/kg 1 h before injection of ET. For three groups, 5 mL blood samples
were collected from postcava for determination of serum creatinine and urea nitrogen
levels at different time points. Concentrations of serum tumor necrosis factor a and ET-1
were determined by using ELISA. The renal pathologic changes were observed under the
microscope.
Results: Serum creatinine levels in both model group and treatment group were
signiﬁcantly higher than control group at T2–T5 (P < 0.05) while the levels in treatment
group were signiﬁcantly lower than control group at T3–T5 (P < 0.05). At T2–T5, blood
urea nitrogen levels in model group and treatment group were signiﬁcantly higher than
control group (P < 0.05) while the levels in treatment group were signiﬁcantly lower than
model group at T3–T5 (P < 0.05). Concentrations of serum tumor necrosis factor a in
model group and treatment group were signiﬁcantly higher than control group at T1–T5
(P < 0.05) while the levels in treatment group were signiﬁcantly lower than model group
at T1–T5 (P < 0.05). Serum ET-1 concentrations in model group and treatment group
were signiﬁcantly higher than control group at T1–T5 (P < 0.05) while the levels in
treatment group at T1–T4 were signiﬁcantly lower than model group (P < 0.05). Rats in
control group showed no swelling or hyperemia in kidney cells but normal structure and
normally arranged renal tubular epithelial cells. Obvious injury was observed in model
group at T3 and renal tubular epithelial cells in disorder and at swelling condition, hy-
peremia and angiectasis in glomerulus, degenerative opacities and vacuolar degeneration,
and maximized injury were observed at T4. Injury in renal tissue in treatment group was
signiﬁcantly milder than model group.
Conclusions: Fasudil hydrochloride has the signiﬁcantly protective effect against acute
renal injury in septicopyemia rats.shuo County, Guilin, Guangxi 541999, China.
014WS012).
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Septicopyemia is the secondary pyogenic infection after severe
trauma,with high virulence of pathogenic bacteria, large diversity,
fast development and severe impact on patients' life and health [1–
3]. The pathogenic bacteria and toxin can spread fast to blood
circulation in septicopyemia patients and further induce general
infection, among which acute renal function damage is the most
severe with the highest mortality rate [4–6]. Septicopyemia is one
of the important reasons for causing acute renal injury; clinical
researches on septicopyemia therapy are many, but reports on
the concomitant acute renal injury are not like that [7]. Fasudil
hydrochloride is the Rho kinase selective inhibitor with
extensive pharmacological effects and signiﬁcant functions of
vascular dilation and anti-inﬂammation [8]. Researches show
that fasudil hydrochloride can effectively decrease the serum
endoxin (ET)-1 concentration in patients with acute renal injury,
with signiﬁcant protective effect on renal tissue during the
course of acute renal injury [9–14]. The present study investigates
the protective effect of fasudil hydrochloride against acute renal
injury in septicopyemia rats. Wister rats were used to establish
acute renal injury models through intraperitoneal injection of ET
and fasudil hydrochloride was used for intervention treatment
1 h before modeling. The efﬁcacy of fasudil hydrochloride on
protection against acute renal injury is observed.
2. Materials and methods
2.1. Experimental animals
A total of 60 male Wister rats aged 8 weeks and weighed
(220 ± 10) g were provided by Animal Experimental Center in
the hospital. They had a free access to food and water, and raised
at (23 ± 3) C with 50%–55% humidity. All the animal han-
dlings accorded with Laboratory Animal Administration Rules.
2.2. Equipments and reagents
BECKMAN SYNCHRON type fully-automatic blood
biochemical analyzer was purchased from USA. Bacterial
endotoxin analyzer (BET-24A) was purchased from Tianda
Tianfa Technology Co., Ltd (Tianjin, China). BH-2 optical mi-
croscope was purchased from OLYMPUS Company, Japan.
Fasudil hydrochloride was purchased from Chase Sun Co., Ltd
(Tianjin, China) with national medicine permission number of
H20040356 (2 mL:30 mg). Escherichia coli ET was purchased
from Sigma Company, USA. ET-1 ELISA kit was purchased
from Blue Gene Company.
2.3. Modeling and animal grouping
Sixty Wister rats were divided into control group (n = 10),
model group (n = 25), and treatment group (n = 25).Table 1
Comparisons of serum creatinine levels at each time point (mmol/L).
Groups T1 T2
Treatment group 64.69 ± 11.03 78.09 ± 10.54*
Model group 67.09 ± 14.08 81.79 ± 12.49*
Control group 50.69 ± 6.21 50.69 ± 6.21
*: P < 0.05 compared with control group; #: P < 0.05 compared with modeIntraperitoneal injection of ET was given to model group and
treatment group to establish the acute renal injury models [15],
while intraperitoneal injection of normal saline 1 mL was
given to control group every day. Feeding was banned 12 h
before modeling in both model group and treatment group.
For these two groups, 5 rats were taken out from each group
for modeling at 1 h (T1), 6 h (T2), 12 h (T3), 24 h (T4) and
48 h (T5) through intraperitoneal injection of ET 30 mg/kg.
For treatment group, intraperitoneal injection of fasudil
hydrochloride 30 mg/kg was given 1 h before ET injection.
2.4. Observational items
For all the groups, 5 mL blood samples were collected from
postcava at each time point for determination of serum creatinine
and blood urea nitrogen levels. Tumor necrosis factor (TNF)-a
and ET-1 concentrations were determined by using ELISA.
Renal pathologic changes in rats were observed under the
microscope.
2.5. Statistical analysis
Data were expressed as mean ± SD and processed by using
SPSS13.0 software. ANOVA was used for comparisons among
groups while t test was for comparisons between groups. Results
with P < 0.05 were considered as statistically signiﬁcant
difference.3. Results
3.1. Comparisons of serum creatinine levels at each time
point
At T2–T5, serum creatinine levels in model group and
treatment group were signiﬁcantly higher than control group
(P < 0.05); while at T3–T5, the levels in treatment group were
signiﬁcantly lower than model group (P < 0.05) (Table 1).
3.2. Comparisons of serum blood urea nitrogen levels at
each time point
At T2–T5, serum blood urea nitrogen levels in model group
and treatment group were signiﬁcantly higher than control group
(P < 0.05); while at T3–T5, the levels in treatment group were
signiﬁcantly lower than model group (P < 0.05) (Table 2).
3.3. Comparisons of serum TNF-a concentrations at
each time point
At T1–T5, serum TNF-a concentrations in model group and
treatment group were signiﬁcantly higher than control group
(P < 0.05); while at T1–T5, the concentrations in treatmentT3 T4 T5
84.09 ± 14.17*# 106.06 ± 23.33*# 93.69 ± 22.90*#
143.29 ± 29.59* 163.29 ± 32.50* 115.29 ± 19.56*
50.69 ± 6.21 50.69 ± 6.21 50.69 ± 6.21
l group.
Table 2
Comparisons of serum blood urea nitrogen levels at each time point (mmol/L).
Groups T1 T2 T3 T4 T5
Treatment group 11.20 ± 3.50 14.07 ± 3.93* 16.65 ± 3.95*# 19.65 ± 4.50*# 12.01 ± 3.65*#
Model group 11.34 ± 4.28 15.07 ± 2.68* 27.81 ± 5.26* 33.59 ± 8.49* 15.67 ± 3.95*
Control group 9.34 ± 4.42 9.34 ± 4.42 9.34 ± 4.42 9.34 ± 4.42 9.34 ± 4.42
*: P < 0.05 compared with control group; #: P < 0.05 compared with model group.
Table 3
Comparisons of serum TNF-a concentrations at each time point (Pg/mL).
Groups T1 T2 T3 T4 T5
Treatment group 74.04 ± 3.95*# 93.08 ± 4.12*# 83.08 ± 3.25*# 118.00 ± 6.71*# 76.24 ± 3.75*#
Model group 95.20 ± 3.94* 164.04 ± 6.81* 183.75 ± 5.95* 158.85 ± 7.94* 99.61 ± 3.89*
Control group 51.60 ± 3.36 51.42 ± 2.97 51.26 ± 2.85 51.03 ± 3.43 52.06 ± 3.26
*: P < 0.05 compared with control group; #: P < 0.05 compared with model group.
Table 4
Comparisons of serum ET-1 concentrations at each time point (ng/mL).
Groups T1 T2 T3 T4 T5
Treatment group 1.18 ± 0.42*# 1.28 ± 0.40*# 1.77 ± 0.22*# 1.29 ± 0.21*# 0.83 ± 0.25*
Model group 1.74 ± 0.81* 2.01 ± 0.61* 2.46 ± 0.50* 1.63 ± 0.24* 0.94 ± 0.22*
Control group 0.34 ± 0.25 0.34 ± 0.25 0.44 ± 0.15 0.44 ± 0.15 0.44 ± 0.15
*: P < 0.05 compared with control group; #: P < 0.05 compared with model group.
Figure 1. Histological observation of renal tissue in three groups (HE, × 200).
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(Table 3).
3.4. Comparisons of serum ET-1 concentrations at each
time point
At T1–T5, serum ET-1 concentrations in model group and
treatment group were signiﬁcantly higher than control group
(P < 0.05); while at T1–T4, the concentrations in treatment
group were signiﬁcantly lower than model group (P < 0.05)
(Table 4).
3.5. Histological observation
In the case of control group, the swelling or hyperemia in
kidney cells was not observed except for the normal structure
and normally arranged renal tubular epithelial cells. Rats inmodel group at T3 showed apparent injury and at T4 the renal
tubular epithelial cells in disorder and at swelling condition,
hyperemia and angiectasis in glomerulus, degenerative opacities
and vacuolar degeneration, and maximized injury were revealed.
Signiﬁcantly milder damage in renal tissue than model group at
each time point was observed in treatment group (Figure 1).
4. Discussion
Acute renal injury is the clinically common critical disease
with urgent onset, fast development and extremely high mor-
tality rate, seriously affecting the prognosis of patients [16].
Septicopyemia caused by infection is one of the important
factors leading to acute renal injury [17]. There are researches
showing that organism at the condition of septicopyemia can
result in involvements of multiple organs, due to that G-
bacterium in endotoxemia nidi can release lots of
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immediately induce acute renal injury [17–19]. Therefore, the
present study establishes acute renal injury models through
intraperitoneal injection of ET into Wister rats. The serum
blood urea nitrogen and creatinine levels in model group at T2
were signiﬁcantly higher than control group (P < 0.05),
suggesting that intraperitoneal injection of ET is fast and
efﬁcient in establishment of acute renal injury models.
Fasudil hydrochloride, the new-type medicine with extensive
pharmacological effects, is the Rho kinase inhibitor, with
functions of dilating blood vessels, improving brain microcir-
culation, reducing tension of endothelial cells, antagonizing in-
ﬂammatory factors, protecting nerves and anti-apoptosis, and
accelerating nerve regeneration [8]. Researches reveal that
fasudil hydrochloride can effectively decrease the serum ET-1
concentration in patients with acute renal injury, with apparent
protection effect on kidneys in the course of acute renal injury
[8]. In the present study, the serum creatinine and blood urea
nitrogen levels in treatment group at T2–T5 were signiﬁcantly
lower than model group, suggesting that fasudil hydrochloride
plays a protective effect on kidneys of rats with acute renal
injury. TNF is called tumor necrosis factor, and mainly
includes TNF-a and TNF-b; TNF-a is mainly produced by
macrophages, with functions of immunoregulation,
antibacterial, and anti-virus, and abnormal TNF-a concentra-
tion may cause a bad effect on organism [20,21]. TNF-a plays a
key role in the pathogenic course of infectious diseases; when
organisms are stimulated by LPS, in vivo TNF-a increase
would be induced [22]. In the present study, serum TNF-a
concentrations in both model group and treatment group were
signiﬁcantly higher than control group at each time point
(P < 0.05), suggesting that release of large amount of LPS in
endotoxemia nidi into blood makes signiﬁcant increase in
TNF-a concentration in vivo and that TNF-a participates in
the pathogenic course of acute renal injury. Serum TNF-a
concentrations in treatment group at T1–T5 were signiﬁcantly
lower than model group (P < 0.05), revealing that fasudil
hydrochloride can effectively antagonize inﬂammatory factors
so as to protect renal tissue. ET-1 is the important cytokine in
organism, spreading all over the organism and gets involved in
regulating a variety of physiological activities and inﬂammatory
reaction though combination with its speciﬁc receptors [22,23]. In
the physiological status, ET-1 is good for maintaining the sta-
bility of organism, however, in the course of endotoxemia,
abnormal changes of ET-1 can cause constant destruction in
organism and further leads to incidence of acute renal injury [24].
In the present study, serum ET-1 concentrations at T1–T5 in
model group and treatment group were signiﬁcantly higher than
control group (P < 0.05), suggesting that ET-1 concentrations in
rats with acute renal injury are signiﬁcantly increased, with
positive correlation property between concentration change and
injury degree. Serum ET-1 concentrations at T1–T4 were
signiﬁcantly lower in treatment group than model group
(P < 0.05), suggesting that fasudil hydrochloride can effectively
regulate the immune response of organism, with signiﬁcantly
protective effect against acute renal injury. In addition, histo-
logical observation shows obvious injury in model group at T3,
and the renal tubular epithelial cells in disorder and at swelling
condition, hyperemia and angiectasis in glomerulus, degenera-
tive opacities and vacuolar degeneration, and maximized injury
at T4. Signiﬁcantly milder injury in kidney tissue in treatment
group at each time point than model group was also observed,which can also conﬁrm that fasudil hydrochloride has a signif-
icantly protective effect against acute renal injury in septico-
pyemia rats.
In conclusion, fasudil hydrochloride plays a signiﬁcantly
preventive and therapeutic role in acute renal injury caused by
septicopyemia.
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